Arthur Taveras

Chief Scientific Officer, X4 Pharmaceuticals, Inc.

Companies

X4 Pharmaceuticals, IncChief Scientific Officer Nov 3, 2020 to Oct 8, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

X4 Pharmaceuticals, Inc XFOR388,026 shares²$995.3K at $2.56Oct 7, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 7, 2024Sold 76,920 shares at $0.56 of X4 Pharmaceuticals, Inc²
Oct 4, 2024Granted 230,645 shares of X4 Pharmaceuticals, Inc²
Mar 11, 2024Sold 14,235 shares at $0.88 of X4 Pharmaceuticals, Inc³
Feb 12, 2024Sold 787 shares at $1.01 of X4 Pharmaceuticals, Inc⁴
Nov 1, 2023Sold 67,695 shares at $0.73 of X4 Pharmaceuticals, Inc⁵
Oct 31, 2023Granted 230,645 shares of X4 Pharmaceuticals, Inc⁶
Mar 10, 2023Sold 16,806 shares at $0.84 of X4 Pharmaceuticals, Inc⁷
Feb 13, 2023Sold 928 shares at $0.93 of X4 Pharmaceuticals, Inc⁸
Mar 1, 2022Granted 97,000 shares of X4 Pharmaceuticals, Inc⁹
Feb 11, 2022Shares withheld for tax 928 shares of X4 Pharmaceuticals, Inc¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARX4 Pharmaceuticals, Inc, Chief Scientific Officer
2
SEC EDGARX4 Pharmaceuticals, Inc shares after the filing of Oct 7, 2024
3
SEC EDGARForm 4 filed Mar 11, 2024
4
SEC EDGARForm 4 filed Feb 12, 2024
5
SEC EDGARForm 4 filed Nov 3, 2023
6
SEC EDGARForm 4 filed Nov 2, 2023
7
SEC EDGARForm 4 filed Mar 13, 2023
8
SEC EDGARForm 4 filed Feb 15, 2023
9
SEC EDGARForm 4 filed Mar 1, 2022
10
SEC EDGARForm 4 filed Feb 14, 2022